Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

How to Reduce 45 percent of US Budget

How to Reduce 45 percent of US Budget


John Milligan-Whyte and Dai Min © 2010 All Rights Reserved


Using cheaper, effective and less painful Chinese medical treatments is an essential part of reducing the U.S. government’s deficit funding of healthcare. China should increase its current roles in using Chinese medical and stem cell treatments and play a new innovative role in understanding medicine as a phenomenon of physics in 21st century, global public health care policy development, medical treatment research, and biotechnology investing.


First China needs induce the U.S. to collaborate with it in the comparative analysis of the costs, effectiveness and patient comfort or discomfort of Chinese and American medicinal treatment approaches to the list from A to Z of human ailments. For many illnesses the Chinese medical approach is cheaper, effective and less painful. For example, in response to a severe back pain making it nearly impossible to walk, the U.S. medical treatment could be a gall bladder operation. The Chinese medical treatment was that the patient eats lots of cucumbers. For whatever reasons, for that patient, the Chinese medicine treatment was tried first and was effective. Another example inserting electrified needles and causing the reduction in size of a cancer tumor. American and Chinese patients, healthcare providers, insurers and public policy makers comparing the cost, effectiveness, and painfulness of Chinese and U.S. medical responses’ to the list of human ailments is urgently required. 


The comparative analysis must be a collaborative effort by American and Chinese medical practitioners, public policymakers and physicists. The U.S. plays the leading roles in innovative research and the use of methods of preventing and treating illness that are not indigenous to China. China plays the leading roles in innovative research and the use of Chinese medicine's prevention and treatment of illness. It has the most research and clinical patient treatment experience in these areas.


Both China and the U.S. are struggling and responding in different ways to their citizens’ health care needs with less than adequate success. China is struggling to provide health care to I.5 billion people with an annual per capita income of about 12 percent of that of the 302 million Americans. The US has annual GDP of US 15 trillion dollars, three times larger than China’s. But, health care is caught up in the U.S.’s relentless economic, unemployment and national, state and local governments’ unsustainable deficit and debt crises. The U.S. federal government is spending 45 percent of its annual federal budget on health care and it has a budget deficit in 2009 of U.S.$ 1.42 trillion. The U.S. government’s debt is projected to reach 100 percent of America’s annual GDP by 2020. The likelihood is low to none existent that the American government and people will be able to pay their debts, borrow to fund their deficits, and sustain the scope and level of health care, which Americans have come to expect. Neither the U.S. government nor people can afford the healthcare they currently have. It confronts Americans with personal and national bankruptcy, as the “baby boomers” born between 1946 and 1964 grow old.


China is the U.S. largest creditor. The U.S. cannot cure an overdose of deficit spending and debt that it cannot repay by creating more debt and printing money. The global bond markets are heading towards collapse. When the full faith and credit of the U.S. government declines, the U.S. government’s ability to fund health care will decline. President Obama is struggling to reduce the costs and to make health care available to all Americans.


The second innovative role which China already leads in and must accelerate, is comparative study of the effectiveness, cost, patient comfort or discomfort of stem cell and non-stem cell treatments. Stem cell research and its clinical use is one of the revolutions in 21st century health care that the U.S. is lagging behind in.


China’s third innovative role is pioneering studying and explaining medicine as a phenomenon of physics and inducing Americans and others to do so. There are few if any medical doctors in the U.S. or China with Ph.D degrees in physics. That must change because medicine is not merely a phenomena of biology, chemistry or genetics. The comparative analysis of U.S. and Chinese medical treatments must include Chinese and U.S. medical doctors and theoretic and experimental physicists working together to understand medicine as a phenomena of physics. Doctors at the leading U.S. hospital are reducing the size of tumors using electrified acupuncture. Decades ago a U.S. physicist and a Chinese doctor independently used and explained why the treatment works.


The authors’ new books, China and America’s Responsibilities in Mankind’s Future and Combining Innovative Research Areas In 21st Century Medicine, are volumes 8 and 9 in their America China Partnership Book Series.


Disclosure: I am long XL.

Additional disclosure: This article will be published this week in my China Daily column.